Cavan Alpha

CAVAN ALPHA- beta carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium carbonate, iron, magnesium oxide, zinc oxide, cupric oxide, iodine, omega-3 fatty acids
Seton Pharmaceuticals

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.


Rx Only


Cavan™- Alpha Kit is a prescription prenatal/postnatal multivitamin/mineral tablet and a softgel with an essential fatty acid.

Each tablet has the following active Ingredient:

Folic Acid 1 mg

Each tablet also contains the following ingredients for nutritional supplementation:

Vitamin A (beta carotene) 3,000 IU
Vitamin C (ascorbic acid) 120 mg
Vitamin D (cholecalciferol) 800 IU
Vitamin E (dl-alpha tocopheryl acetate) 3 mg
Vitamin B1 (thiamine mononitrate) 1.8 mg
Vitamin B2 (riboflavin) 4 mg
Niacinamide 20 mg
Vitamin B6 (pyridoxine hydrochloride) 50 mg
Vitamin B12 (cyanocobalamin) 12 mcg
Calcium (calcium carbonate) 230 mg
Iron (polysaccharide iron complex and
sodium iron EDTA)
27 mg
Magnesium (magnesium oxide) 25 mg
Zinc (zinc oxide) 25 mg
Copper (cupric oxide) 2 mg
Iodine 220 mcg

Each softgel contains the following ingredients for nutritional supplementation:

Total omega-3 long chain fatty acids at least 300 mg*
As DHA 200 mg**
As other omega-3 long-chain fatty acids 100 mg**
* from at least 429 mg of purified fish oil. ** approximately.

Inactive Ingredients (tablet): Ascorbyl Palmitate, Citric Acid, Croscarmellose Sodium, Ethyl Cellulose, FD&C Blue #1, FD&C Yellow #5, Fumed Silica, Gum Arabic, Hydroxypropyl Cellulose, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Glycol, Polysorbate 80, PVP K30, Stearic Acid, Talc, Titanium Dioxide, TriPotassium Citrate, Vegetable Oil.

Inactive Ingredients (softgel): Acetyl a ted Monoglycerides, Ethyl Vanillin, Gelatin, Glycerin, Polysorbate 80, Potassium Sorb ate, Purified Water, Shellac Ammonium Salt, Sodium Alginate, Specially Denatured Alcohol, Stearic Acid, Vitamin E.

Cavan Alpha Indications and Usage

Cavan™-Alpha Kit is indicated for the supplemental requirements of patients with nutritional deficiencies or are in need of nutritional supplementation.


This product is contraindicated in patients with a known hypersensitivity to any of the ingredients, including fish and fish oil.


Daily ingestion of more than 3 g per day of omega-3 fatty acids (ALA. EPA, and DHA) from fish oils may have potential antithrombotic activities, or effects, and may increase bleeding times. Administration of omega-3 fatty acids-including DHA, should be avoided in patients with inherited or acquired bleeding diatheses, including those taking anticoagulants.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

This product contains fish oil.


General: Folic acid, when administered as a single agent in doses above 0.1 mg daily, may obscure the detection of B12 deficiency {specifically, the administration of folic acid may reverse the hematological manifestations of B12 deficiency, including pernicious anemia, while not addressing the neurological manifestations). Reduced folates may be less likely than folic acid to mask vitamin B12 deficiency. Folate therapy alone is Inadequate for the treatment of B12 deficiency.


Cavan™- Alpha Kit is a prescription vitamin for use only under the direction and supervision of a licensed physician.


Pyridoxine hydrochloride should not be given to patients receiving the drug levodopa, because the action of levodopa is antagonized by pyridoxine hydrochloride. However, pyridoxine hydrochloride may be used concurrently in patients receiving a preparation containing both carbidopa and levodopa.

Drugs which may interact with folate include:

  • Anti epileptic drugs (AED): The AED class including, but not limited to, phenytoin, carbamazepine, primidone, valproic acid, phenobarbital and lamotrigine have been shown to impair folate absorption and increase the metabolism of circulating folate. Additionally, concurrent use of folic acid has been associated with enhanced phenytoin metabolism, lowering the level of this AED in the blood and allowing breakthrough seizures to occur.
  • Capecitabine: Folinic acid (5-formyltetrahydrofolate) may increase the toxicity of Capecitabine.
  • Cholestyramlne: Reduces folic acid absorption and reduces serum folate levels.
  • Colestipol: Reduces folic acid absorption and reduces serum folate levels.
  • Cycloserine: Reduces folic acid absorption and reduces serum folate levels.
  • Dihydrofolate Reductase Inhibitors (DHFRI): DHFRIs block the conversion of folic acid to its active forms, and lower plasma and red blood cell folate levels. DHFRls include aminopterin, methotrexate, pyrimethamine, triamterene, and trimethoprim.
  • Fluoxetine: Fluoxetine exerts a noncompetitive inhibition of the 5-methyltetrahydrofolate active transport in the intestine.
  • lsotretinoin: Reduced folate levels have occurred in some patients taking isotretinoin.
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): NSAIDs have been shown to inhibit some folate dependent enzymes in laboratory experiments. NSAIDs include ibuprofen, naproxen, indomethacin and sulindac.
  • Oral Contraceptives: Serum folate levels may be depressed by oral contraceptive therapy.
  • Methylprednisolone: Reduced serum folate levels have been noted after treatment with methylprednisolone.
  • Pancreatic Enzymes: Reduced folate levels have occurred in some patients taking pancreatic extracts.
  • Pentamidine: Reduced folate levels have been seen with prolonged intravenous pentamidine.
  • Smoking and Alcohol: Reduced serum folate levels have been noted.
  • Sulfasalazine: Inhibits the absorption and metabolism of folic acid.
  • Metformin treatment in patients with type 2 diabetes decreases serum folate.
  • Warfarin can produce Significant impairment In folate status after a 6-month therapy.
Page 1 of 2 1 2

All resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.